Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Gimatecan in Malignant Glioma
NCT00032903Phase 2Completed
- Sponsor
- Leadiant Biosciences
- Start
- Mar 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gimatecan in malignant glioma, sponsored by Leadiant Biosciences. Started Mar 2002; status: completed.
02
Drugs
gimatecan
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00032903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00032903.